In our analysis, we adopted a strategy to identify mRNAs related to the PI3K/AKT/mTOR pathway, which differentiate between the five subtypes of breast cancer, as well as transcripts common to all breast cancer types. This evidence concerns the gene AKT1 and breast carcinoma.